Chat With Us on Whatsapp
Merger and acquisition activity has been rather slow in the biopharma industry so far this year. Pharmaceuticals and life sciences (PLS) and healthcare services (HCS) continued to attract high levels of investor interest throughout 2021, led by innovations in biotechnology and patient services.
Competition between large pharma companies and institutional investors—venture capital (VC), initial public offerings (IPOs), etc.—remains high, particularly for medium-sized biotech platforms.
As multiples continue to increase, buyers need to define their post-deal value capture-and-creation plans.
Companies with well-crafted long-term plans will be able to unlock value in the current market, while those that take a hands-off approach may struggle to earn the desired return on investment.
Pharmaceuticals Businesses for Sale, Established Pharmaceutical Companies for Sale, Pharmaceuticals Manufacturing Business for sale, Best Pharma company for sale. Check the latest Pharmaceuticals listings of companies for sale.get your valuation